 |
0 Diseases |  |
3 Trials |
|
3 Trials |  |
67 News |  |
- | amiodarone / Generic mfg.
Trial initiation date: Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer (clinicaltrials.gov) - Apr 4, 2024
P2, N=90, Not yet recruiting, Sponsor: OHSU Knight Cancer Institute
Initiation date: Jan 2024 --> May 2024
- | Brinavess (vernakalant) / Merck (MSD), Correvio
Trial completion date, Trial primary completion date, Surgery: Vernakalant Versus Amiodarone for Post-operative Atrial Fibrillation in Cardiac Surgery Patients (clinicaltrials.gov) - May 24, 2023
P3, N=50, Not yet recruiting, Sponsor: University of Calgary
Initiation date: Jan 2024 --> May 2024 Trial completion date: Sep 2024 --> Sep 2025 | Trial primary completion date: Jan 2024 --> Jan 2025
- | Brinavess (vernakalant) / Merck (MSD), Correvio
Trial completion date, Trial primary completion date, Surgery: Vernakalant Versus Amiodarone for Post-operative Atrial Fibrillation in Cardiac Surgery Patients (clinicaltrials.gov) - Nov 4, 2022
P3, N=50, Not yet recruiting, Sponsor: University of Calgary
Trial completion date: Sep 2024 --> Sep 2025 | Trial primary completion date: Jan 2024 --> Jan 2025 Trial completion date: Sep 2023 --> Sep 2024 | Trial primary completion date: Sep 2023 --> Jan 2024
- | Brinavess (vernakalant) / Merck (MSD), Correvio
Trial primary completion date, Surgery: Vernakalant Versus Amiodarone for Post-operative Atrial Fibrillation in Cardiac Surgery Patients (clinicaltrials.gov) - May 18, 2022
P3, N=50, Not yet recruiting, Sponsor: University of Calgary
Trial completion date: Sep 2023 --> Sep 2024 | Trial primary completion date: Sep 2023 --> Jan 2024 Trial primary completion date: Jan 2023 --> Sep 2023
- | amiodarone / Generic mfg.
Enrollment open: AAA: Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study (clinicaltrials.gov) - Feb 24, 2022
P4, N=42, Recruiting, Sponsor: University of Calgary
Trial primary completion date: Jan 2023 --> Sep 2023 Not yet recruiting --> Recruiting
- | Brinavess (vernakalant) / Merck (MSD), Correvio
Trial completion date, Trial initiation date, Trial primary completion date, Surgery: Vernakalant Versus Amiodarone for Post-operative Atrial Fibrillation in Cardiac Surgery Patients (clinicaltrials.gov) - Sep 30, 2021
P3, N=50, Not yet recruiting, Sponsor: University of Calgary
Not yet recruiting --> Recruiting Trial completion date: Aug 2022 --> Aug 2023 | Initiation date: Jul 2021 --> Jan 2022 | Trial primary completion date: Jul 2022 --> Jan 2023
- | amiodarone / Generic mfg.
Trial initiation date: AAA: Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study (clinicaltrials.gov) - Sep 9, 2021
P4, N=42, Not yet recruiting, Sponsor: University of Calgary
Trial completion date: Aug 2022 --> Aug 2023 | Initiation date: Jul 2021 --> Jan 2022 | Trial primary completion date: Jul 2022 --> Jan 2023 Initiation date: Jun 2021 --> Sep 2021
- | Brinavess (vernakalant) / Merck (MSD), Correvio
Trial initiation date, Trial primary completion date, Surgery: Vernakalant Versus Amiodarone for Post-operative Atrial Fibrillation in Cardiac Surgery Patients (clinicaltrials.gov) - Apr 29, 2021
P3, N=50, Not yet recruiting, Sponsor: University of Calgary
Initiation date: Jun 2021 --> Sep 2021 Initiation date: Mar 2021 --> Jul 2021 | Trial primary completion date: Mar 2022 --> Jul 2022
- | Brinavess (vernakalant) / Merck (MSD), Correvio
New P3 trial, Surgery: Vernakalant Versus Amiodarone for Post-operative Atrial Fibrillation in Cardiac Surgery Patients (clinicaltrials.gov) - Feb 10, 2021
P3, N=50, Not yet recruiting, Sponsor: University of Calgary
- | amiodarone / Generic mfg.
New P4 trial: AAA: Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study (clinicaltrials.gov) - Oct 19, 2020
P4, N=42, Not yet recruiting, Sponsor: University of Calgary
- ||| Nexterone (captisol enabled amiodarone) / Baxter Healthcare
Clinical: To be fair our hospital uses the nexterone product for first dose boluses so probably ubiquitous? :) (Twitter) - Mar 14, 2020
- || Nexterone (captisol enabled amiodarone) / Baxter Healthcare
GlaxoSmithKline @GSKUS has a number of oncology-related job openings and if you'll be at #ASHG19 in Houston this week- you can visit GSK Careers at booth 1049 #sciencejobs #oncology #genetics #genomics #PM101 (Twitter) - Oct 14, 2019
- ||||| Nexterone (captisol enabled amiodarone) / Baxter Healthcare
Clinical, Interview: Inspiring interview w/ rare disease patient & UPenn doctor & genetics expert @DavidFajgenbaum by @matthewherper. He was in medical school when he got sick, studied his disease & proposed repurposing little known drug sirolimus for Castleman Disease. https://t.co/UZW9Wo5lTL #PM101 (Twitter) - Sep 14, 2019
- Nexterone (captisol enabled amiodarone) / Baxter Healthcare
Enrollment change: A Randomized, Placebo-Controlled, Double-Blind, Double Dummy Trial To Determine The Relative Effect Of Pm101 Versus Placebo And Amiodarone IV On Blood Pressure In Subjects With Stable Congestive Heart Failure (clinicaltrials.gov) - Sep 11, 2017
P2, N=0, Withdrawn, Sponsor: Prism Pharmaceuticals
Initiation date: Mar 2021 --> Jul 2021 | Trial primary completion date: Mar 2022 --> Jul 2022 N=75 --> 0
- ||||||| amiodarone / Generic mfg.
Trial completion: Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia (clinicaltrials.gov) - Apr 17, 2017
P3, N=3024, Completed, Sponsor: University of Washington
N=75 --> 0 Active, not recruiting --> Completed
- ||||| amiodarone / Generic mfg.
Enrollment closed: Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia (clinicaltrials.gov) - Dec 5, 2015
P3, N=3000, Active, not recruiting, Sponsor: University of Washington
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- |||| amiodarone / Generic mfg.
Trial primary completion date: Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia (clinicaltrials.gov) - Apr 15, 2015
P3, N=3000, Recruiting, Sponsor: University of Washington
Recruiting --> Active, not recruiting Trial primary completion date: Mar 2015 --> Oct 2015
- | amiodarone / Generic mfg.
Enrollment open: Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia (clinicaltrials.gov) - May 21, 2012
P3, N=3000, Recruiting, Sponsor: University of Washington
Trial primary completion date: Mar 2015 --> Oct 2015 Not yet recruiting --> Recruiting